Maintenance Therapy with Immunomodulatory Drugs after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Although high-dose therapy (HDT) with autologous stem cell transplantation (ASCT) has been confirmed to result in longer remission time than conventional chemotherapy, multiple myeloma (MM) remains incurable. Post-ASCT maintenance is considered as a strategy for obtaining durable remissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Xueshi, Huang, Jinwen, Pan, Qin, Li, Wanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747129/
https://www.ncbi.nlm.nih.gov/pubmed/23977334
http://dx.doi.org/10.1371/journal.pone.0072635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747129/
https://www.ncbi.nlm.nih.gov/pubmed/23977334
http://dx.doi.org/10.1371/journal.pone.0072635

Ejemplares similares